PharmaShots | Incisive News in 3 Shots

Subscribe Now

ZUMA-2 Study

Kite's Tecartus (KTE-X19) Receives EC's Conditional Marketing Authorization for R/R Mantle Cell Lymphoma

Kite's Tecartus (KTE-X19) Receives EC's Conditional Marketing Authorization for R/R Mantle Cell Lymphoma

December 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us